We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Motivational Interviewing to Prevent Suicide in High Risk Veterans

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01544127
First Posted: March 5, 2012
Last Update Posted: November 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
VA Office of Research and Development
February 28, 2012
March 5, 2012
November 30, 2017
July 30, 2012
December 5, 2017   (Final data collection date for primary outcome measure)
Severity of Suicidal Ideation [ Time Frame: Six months ]
The severity of suicidal ideation will be measured using the Beck Scale for Suicidal Ideation (SSI) at baseline, 1, 3, and 6 months after discharge.
Same as current
Complete list of historical versions of study NCT01544127 on ClinicalTrials.gov Archive Site
Treatment Engagement [ Time Frame: Six months ]
Treatment engagement will be measured using the Treatment Services Review-6 (TSR-6) at baseline, 1, 3, and 6 months after discharge.
Same as current
Suicide Attempts [ Time Frame: Six months ]
Suicide attempts will be measured with the Columbia Suicide Severity Rating Scale (C-SSRS) at baseline, 1, 3, and 6 months after discharge.
Not Provided
 
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Motivational Interviewing to Prevent Suicide in High Risk Veterans
The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide.
Veterans who receive health care from the VA are at elevated risk for suicide, and the number of Veterans at high risk may be growing. Although the months following discharge from psychiatric hospitalization are a period of acute risk for Veterans, there is a dearth of empirically supported treatments tailored to psychiatric inpatients and no studies examining treatments for psychiatrically hospitalized Veterans. This randomized controlled trial will test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized Veterans at high risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at the Syracuse VA Medical Center. To meet high-risk criteria, Veterans must score over two on the Beck Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by suicide. Participants will complete a screening assessment to confirm eligibility and a baseline assessment of risk factors for suicide. They will be randomized to receive Motivational Interviewing to Address Suicidal Ideation (MI-SI) plus treatment as usual (TAU), or TAU alone. The MI-SI group will receive two sessions of MI-SI during hospitalization and one telephone booster session after discharge. Participants in both conditions will be asked to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in the severity of suicidal ideation will be measured using the SSI.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
  • Suicidal Ideation
  • Treatment Engagement
  • Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
    1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
    Other Name: MI-SI 1
  • Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)- Revised
    1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
    Other Name: MI-SI 2
  • Experimental: MI-SI 1
    Motivational Interviewing to Address Suicidal Ideation (MI-SI)
    Intervention: Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
  • No Intervention: Arm 2
    Treatment as Usual (TAU)
  • Experimental: MI-SI 2
    Motivational Interviewing to Address Suicidal Ideation (MI-SI)- Revised
    Intervention: Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)- Revised
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
132
December 5, 2017
December 5, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Veteran status,
  • admitted to psychiatric inpatient unit,
  • age 18 and over,
  • English speaking,
  • able to understand the study and provide informed consent,
  • clinically cleared to participate by unit staff,
  • receive health care from a VA facility in upstate NY,
  • at increased risk for suicide (Beck Scale for Suicidal Ideation [SSI] > 2)

Exclusion Criteria:

  • current psychosis,
  • current mania,
  • dementia,
  • prisoner status,
  • being inaccessible and discharged from the unit less than 48 hours after being identified by study staff
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01544127
MHBA-20-11S
IK2CX00064 ( Other Grant/Funding Number: Department of Veterans Affairs )
Yes
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Plan to Share IPD: Undecided
VA Office of Research and Development
VA Office of Research and Development
Not Provided
Principal Investigator: Peter C. Britton, PhD MS Syracuse VA Medical Center, Syracuse, NY
VA Office of Research and Development
November 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP